CCL2 and diabetes mellitus: In a study carried out by Dabrowska-Zamojcin et al., the CCL2 rs1024611 polymorphism was shown to be associated with the development of post-transplantation diabetes mellitus in patients receiving calcineurin inhibitors [9].